US Patent Issued to Memorial Sloan-Kettering Cancer Center, Memorial Hospital for Cancer and Allied Diseases, Sloan-Kettering Institute for Cancer Research on Sept. 8 for "Systems and methods for high dose rate brachytherapy treatment planning using constraint optimization" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,282, issued on Sept. 8, was assigned to Memorial Sloan-Kettering Cancer Center (New York), Memorial Hospital for Cancer and Allied Diseases (New York) and Sloan-Kettering Institute for Cancer Research (New York).

"Systems and methods for high dose rate brachytherapy treatment planning using constraint optimization" was invented by Antonio Damato (White Plains, N.Y.), Joel Beaudry (New York) and Gil'ad Cohen (Tenafly, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods for HDR brachytherapy planning can include obtaining patient specific data of a patient, and determining, using the patient specific data, an optimization problem t...